RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancer

File Description SizeFormat 
Rad51 in ovarian cancer.docxAccepted version13.57 kBMicrosoft WordView/Open
Title: RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancer
Authors: Hoppe, MM
Tan, DSP
Lim, DGZ
Karnezis, A
Huntsman, D
Steel, J
Liu, X
Paul, J
Lewsley, L-A
Siddiqui, N
Brown, R
Jeyasekharan, AD
Item Type: Conference Paper
Issue Date: 1-Oct-2017
Date of Acceptance: 4-Jan-2017
URI: http://hdl.handle.net/10044/1/61834
DOI: https://dx.doi.org/10.1158/1538-8514.SYNTHLETH-B04
ISSN: 1535-7163
Publisher: American Association for Cancer Research
Journal / Book Title: MOLECULAR CANCER THERAPEUTICS
Volume: 16
Issue: 10
Copyright Statement: © 2017 American Association for Cancer Research.
Conference Name: AACR Precision Medicine Series: Opportunities and Challenges of Exploiting Synthetic Lethality in Cancer
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
1115 Pharmacology And Pharmaceutical Sciences
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2017-01-04
Finish Date: 2017-01-07
Conference Place: San Diego, CA
Online Publication Date: 2017-10-01
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx